Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 10
Submit an article Journal homepage
407
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER

Julia F. Slejko University of Colorado School of Pharmacy, Aurora, CO USACorrespondence[email protected]
,
Robert L. Page II University of Colorado Schools of Pharmacy and Medicine, Departments of Clinical Pharmacy and Physical Medicine, Aurora, CO USA
&
Patrick W. Sullivan Regis University, Rueckert-Hartman College for Health Professions, Department of Pharmacy Practice, Denver, CO USA
Pages 2485-2497 | Accepted 17 Aug 2010, Published online: 10 Sep 2010

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Dong-Churl Suh, Scott K. Griggs, Emmett R. Henderson, Seung-Mi Lee & Taehwan Park. (2018) Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 51-69.
Read now
Ronen Arbel & Dan Greenberg. (2017) Using lower cost statins improves outcomes for normal cholesterol non-diabetic patients. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 495-501.
Read now
Jesse D. Ortendahl, Amanda L. Harmon, Tanya G. K. Bentley & Michael S. Broder. (2017) A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies. Journal of Medical Economics 20:7, pages 767-775.
Read now
Anuraag R. Kansal, Ying Zheng, Roberto Palencia, Antonio Ruffolo, Bastian Hass & Sonja V. Sorensen. (2013) Modeling hard clinical end-point data in economic analyses. Journal of Medical Economics 16:11, pages 1327-1343.
Read now

Articles from other publishers (10)

Laura V. Minard, Amber Corkum, Ingrid Sketris, Judith Fisher, Ying Zhang & Ahmed Saleh. (2016) Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis. PLOS ONE 11:7, pages e0158608.
Crossref
Lun Li, Peizhen Zhang, Jin Hui Tian & KeHu Yang. (2014) Statins for primary prevention of venous thromboembolism. Cochrane Database of Systematic Reviews.
Crossref
Julia F. Slejko, Patrick W. Sullivan, Heather D. Anderson, P. Michael Ho, Kavita V. Nair & Jonathan D. Campbell. (2014) Dynamic Medication Adherence Modeling in Primary Prevention of Cardiovascular Disease: A Markov Microsimulation Methods Application. Value in Health 17:6, pages 725-731.
Crossref
Habibollah Esmaily, Mohammad Taghi Shakeri, Zeynab Avazzadeh, Hasan Doosti & Majid Ghayour Mobarhan. (2013) Comparison Between Applicability of the Logit and Probit Models to Diagnose Influencing Risk Factors of Cardiovascular Disease in Mashhad. Health Scope 2:2, pages 67-72.
Crossref
Habibollah Esmaily, Mohammad Taghi Shakeri, Zeynab Avazzadeh, Hasan Doosti & Majid Ghayour Mobarhan. (2013) Comparison Between Applicability of the Logit and Probit Models to Diagnose Influencing Risk Factors of Cardiovascular Disease in Mashhad. Health Scope 2:2, pages 67-72.
Crossref
Devin M. Mann, Daichi Shimbo, Mary Cushman, Susan Lakoski, Philip Greenland, Roger S. Blumenthal, Erin D. Michos, Donald M. Lloyd‐Jones & Paul Muntner. (2012) C‐Reactive Protein Level and the Incidence of Eligibility for Statin Therapy: The Multi‐Ethnic Study of Atherosclerosis. Clinical Cardiology 36:1, pages 15-20.
Crossref
Lun Li, TianTian Sun, Peizhen Zhang, Jinhui Tian & KeHu Yang. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Pratik Bhattacharya & Seemant Chaturvedi. (2011) Dyslipidemia Management. CONTINUUM: Lifelong Learning in Neurology 17, pages 1242-1254.
Crossref
Russell H. Samson & Deepak G. Nair. (2011) Influence and Critique of the JUPITER Trial (Statins v No Statins for Primary Prevention of Cardiovascular Events in Patients with Normal Lipids and Elevated C-Reactive Protein). Seminars in Vascular Surgery 24:3, pages 172-179.
Crossref
Thura T. Abd, Danny J. Eapen, Ambareesh Bajpai, Abhinav Goyal, Allen Dollar & Laurence Sperling. (2011) The Role of C-Reactive Protein as a Risk Predictor of Coronary Atherosclerosis: Implications from the JUPITER Trial. Current Atherosclerosis Reports 13:2, pages 154-161.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.